Bio Total Assets from 2010 to 2024

TECH Stock

USD 74.69 1.27 1.67%

Bio Techne's Total Assets are increasing with slightly volatile movements from year to year. Total Assets are estimated to finish at about 3 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1989-09-30

Previous Quarter

2.8 B

Current Value

2.7 B

Quarterly Volatility

824.8 M

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 117.3 M, Total Revenue of 1.2 B or Gross Profit of 811.7 M, as well as many indicators such as Price To Sales Ratio of 6.9, Dividend Yield of 0.0042 or PTB Ratio of 6.78. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.

Check out the analysis of Bio Techne Correlation against competitors.

Latest Bio Techne's Total Assets Growth Pattern

Below is the plot of the Total Assets of Bio Techne Corp over the last few years. Total assets refers to the total amount of Bio Techne assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bio Techne Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Bio Techne's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.81 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Bio Total Assets Regression Statistics

	Arithmetic Mean	1,638,948,500
	Geometric Mean	1,093,390,376
	Coefficient Of Variation	53.08
	Mean Deviation	720,380,400
	Median	1,593,202,000
	Standard Deviation	869,879,847
	Sample Variance	756690.9T
	Range	2.9B
	R-Value	0.99
	Mean Square Error	15211.3T
	R-Squared	0.98
	Slope	192,687,073
	Total Sum of Squares	10593673.3T

Bio Total Assets History

	2024	3 B
	2023	2.8 B
	2022	2.6 B
	2021	2.3 B
	2020	2.3 B
	2019	2 B
	2018	1.9 B

Other Fundumenentals of Bio Techne Corp

Intangibles To Total Assets

Bio Techne Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.74	0.98	0.98	0.93	0.87	0.63	0.62	0.89	-0.39	0.74	0.79	0.78	0.97	0.91	0.01	0.92	0.74	0.63	0.0	0.79	0.12	0.89	0.63
Total Stockholder Equity	0.98		0.62	0.98	0.97	0.85	0.91	0.6	0.54	0.8	-0.37	0.79	0.67	0.77	0.93	0.88	0.17	0.94	0.64	0.62	-0.04	0.68	0.11	0.89	0.68
Net Debt	0.74	0.62		0.65	0.72	0.91	0.37	0.46	0.62	0.89	-0.37	0.4	0.93	0.53	0.84	0.78	-0.46	0.59	0.78	0.51	0.12	0.89	0.15	0.65	0.35
Retained Earnings	0.98	0.98	0.65		0.94	0.87	0.91	0.6	0.6	0.85	-0.31	0.72	0.72	0.77	0.93	0.83	0.05	0.87	0.69	0.53	0.01	0.71	0.11	0.84	0.6
Net Receivables	0.98	0.97	0.72	0.94		0.89	0.82	0.51	0.55	0.84	-0.49	0.8	0.74	0.7	0.95	0.93	0.11	0.95	0.71	0.59	0.0	0.74	0.15	0.88	0.69
Total Liab	0.93	0.85	0.91	0.87	0.89		0.7	0.64	0.7	0.97	-0.4	0.55	0.95	0.73	0.97	0.87	-0.31	0.79	0.87	0.59	0.08	0.93	0.12	0.8	0.46
Total Current Assets	0.87	0.91	0.37	0.91	0.82	0.7		0.64	0.49	0.65	-0.09	0.65	0.54	0.74	0.76	0.64	0.21	0.81	0.55	0.58	-0.03	0.57	0.04	0.8	0.55
Short Term Debt	0.63	0.6	0.46	0.6	0.51	0.64	0.64		0.81	0.69	0.07	0.05	0.56	0.91	0.64	0.56	-0.26	0.54	0.63	0.65	-0.04	0.55	-0.34	0.68	0.07
Accounts Payable	0.62	0.54	0.62	0.6	0.55	0.7	0.49	0.81		0.82	-0.16	0.02	0.69	0.81	0.69	0.59	-0.45	0.45	0.77	0.39	0.13	0.63	-0.53	0.6	0.07
Intangible Assets	0.89	0.8	0.89	0.85	0.84	0.97	0.65	0.69	0.82		-0.39	0.42	0.92	0.78	0.95	0.84	-0.4	0.71	0.86	0.5	0.1	0.87	-0.03	0.75	0.35
Short Term Investments	-0.39	-0.37	-0.37	-0.31	-0.49	-0.4	-0.09	0.07	-0.16	-0.39		-0.51	-0.32	-0.16	-0.47	-0.6	-0.12	-0.48	-0.33	-0.07	-0.01	-0.29	-0.13	-0.33	-0.48
Common Stock	0.74	0.79	0.4	0.72	0.8	0.55	0.65	0.05	0.02	0.42	-0.51		0.39	0.32	0.64	0.7	0.54	0.83	0.3	0.47	-0.11	0.43	0.35	0.7	0.91
Long Term Debt	0.79	0.67	0.93	0.72	0.74	0.95	0.54	0.56	0.69	0.92	-0.32	0.39		0.59	0.86	0.72	-0.5	0.6	0.87	0.52	0.2	0.98	0.11	0.68	0.34
Property Plant Equipment	0.78	0.77	0.53	0.77	0.7	0.73	0.74	0.91	0.81	0.78	-0.16	0.32	0.59		0.78	0.73	-0.1	0.71	0.7	0.6	-0.07	0.59	-0.29	0.81	0.39
Good Will	0.97	0.93	0.84	0.93	0.95	0.97	0.76	0.64	0.69	0.95	-0.47	0.64	0.86	0.78		0.94	-0.14	0.88	0.81	0.59	0.04	0.83	0.1	0.86	0.54
Current Deferred Revenue	0.91	0.88	0.78	0.83	0.93	0.87	0.64	0.56	0.59	0.84	-0.6	0.7	0.72	0.73	0.94		0.04	0.93	0.7	0.65	-0.04	0.7	0.08	0.88	0.62
Net Tangible Assets	0.01	0.17	-0.46	0.05	0.11	-0.31	0.21	-0.26	-0.45	-0.4	-0.12	0.54	-0.5	-0.1	-0.14	0.04		0.3	-0.4	0.14	-0.29	-0.44	0.09	0.17	0.52
Capital Surpluse	0.92	0.94	0.59	0.87	0.95	0.79	0.81	0.54	0.45	0.71	-0.48	0.83	0.6	0.71	0.88	0.93	0.3		0.57	0.73	-0.12	0.61	0.13	0.92	0.74
Deferred Long Term Liab	0.74	0.64	0.78	0.69	0.71	0.87	0.55	0.63	0.77	0.86	-0.33	0.3	0.87	0.7	0.81	0.7	-0.4	0.57		0.39	0.15	0.86	-0.03	0.65	0.31
Long Term Investments	0.63	0.62	0.51	0.53	0.59	0.59	0.58	0.65	0.39	0.5	-0.07	0.47	0.52	0.6	0.59	0.65	0.14	0.73	0.39		-0.34	0.56	-0.01	0.76	0.44
Short Long Term Debt	0.0	-0.04	0.12	0.01	0.0	0.08	-0.03	-0.04	0.13	0.1	-0.01	-0.11	0.2	-0.07	0.04	-0.04	-0.29	-0.12	0.15	-0.34		0.19	0.05	0.04	-0.11
Long Term Debt Total	0.79	0.68	0.89	0.71	0.74	0.93	0.57	0.55	0.63	0.87	-0.29	0.43	0.98	0.59	0.83	0.7	-0.44	0.61	0.86	0.56	0.19		0.17	0.69	0.41
Net Invested Capital	0.12	0.11	0.15	0.11	0.15	0.12	0.04	-0.34	-0.53	-0.03	-0.13	0.35	0.11	-0.29	0.1	0.08	0.09	0.13	-0.03	-0.01	0.05	0.17		-0.01	0.18
Net Working Capital	0.89	0.89	0.65	0.84	0.88	0.8	0.8	0.68	0.6	0.75	-0.33	0.7	0.68	0.81	0.86	0.88	0.17	0.92	0.65	0.76	0.04	0.69	-0.01		0.69
Capital Stock	0.63	0.68	0.35	0.6	0.69	0.46	0.55	0.07	0.07	0.35	-0.48	0.91	0.34	0.39	0.54	0.62	0.52	0.74	0.31	0.44	-0.11	0.41	0.18	0.69

Click cells to compare fundamentals

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's Total Assets, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Total Assets	2.8 B	3 B
Intangibles To Total Assets	0.53	0.55

Currently Active Assets on Macroaxis

CRM	Salesforce
CRM	Salesforce
S	SentinelOne
V	Visa Class A
GOOG	Alphabet Inc Class C

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Techne's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Bio Techne Correlation against competitors.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.32)

Dividend Share

0.32

Earnings Share

0.95

Revenue Per Share

7.424

Quarterly Revenue Growth

0.045

The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bio Total Assets from 2010 to 2024

Latest Bio Techne's Total Assets Growth Pattern

Bio Total Assets Regression Statistics

Bio Total Assets History

Other Fundumenentals of Bio Techne Corp

Bio Techne Total Assets component correlations

About Bio Techne Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY